Suchergebnisse - "Yokoyama, Keitaro"

PubPharm (317)

41

Randomised clinical trial of ferric citrate hydrate on anaemia management in haemodialysis patients with hyperphosphataemia : ASTRIO study

enthalten in: Scientific reports | 2019

von Yokoyama, K. | Fukagawa, M. | Akiba, T. | +5

42

Long-Term Efficacy and Safety of Evocalcet in Japanese Patients with Secondary Hyperparathyroidism Receiving Hemodialysis

enthalten in: Scientific reports | 2019

von Yokoyama, K. | Shimazaki, R. | Fukagawa, M. | +17

43

Evaluation of changes in ferritin levels during sucroferric oxyhydroxide treatment

enthalten in: Clinical kidney journal | 2019

von Koiwa, F. | Yokoyama, K. | Fukagawa, M. | +1

44

Clinical outcome of incident peritoneal dialysis patients with diabetic kidney disease

enthalten in: Clinical and experimental nephrology | 2019

von Kishida, K. | Maruyama, Y. | Asari, K. | +7

45

Effect of bixalomer on coronary artery calcification in hemodialysis patients with hyperphosphatemia: a multi-center, randomized controlled trial

enthalten in: Renal replacement therapy | 2019

von Akiba, T. | Yokoyama, K. | Hase, H. | +5

46

Effect of diabetes on incidence of peritoneal dialysis-associated peritonitis

enthalten in: PloS one | 2019

von Ueda, R. | Nakao, M. | Maruyama, Y. | +9

47

Hepcidin/Ferritin Ratios Differ Among Non‐Dialyzed Chronic Kidney Disease Patients, and Patients on Hemodialysis and Peritoneal Dialysis

enthalten in: Therapeutic Apheresis and Dialysis | 2019

von Niikura, T. | Maruyama, Y. | Nakashima, S. | +6

48

Effect of Oral Alfacalcidol on Clinical Outcomes in Patients Without Secondary Hyperparathyroidism Receiving Maintenance Hemodialysis : The J-DAVID Randomized Clinical Trial

enthalten in: JAMA | 2018

von J-DAVID Investigators | Shoji, T. | Inaba, M. | +59

CommentIn: JAMA. 2018 Dec 11;320(22):2319-2321. - PMID 30535205

49

Effects of the Intravenous Calcimimetic Etelcalcetide on Bone Turnover and Serum Fibroblast Growth Factor 23 : Post Hoc Analysis of an Open-label Study

enthalten in: Clinical therapeutics | 2018

von Shigematsu, T. | Fukagawa, M. | Yokoyama, K. | +4

50

AGENT FOR TREATMENT OF FIBROTIC DISEASES

enthalten in: Europäisches Patentamt | 2018

von MIYAJI HIROYUKI | YANAGISAWA JUN | YOKOYAMA KEITARO